Quantcast

Latest Nycomed Stories

2011-03-02 15:05:00

CUPERTINO, Calif., March 2, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months and year ended December 31, 2010. Total revenues were $8.5 million for the three months ended December 31, 2010, up from $4.9 million for the three months ended December 31, 2009. Net loss for the three months ended December 31, 2010 was $5.3 million, down from a net loss of $8.6 million for the same period in 2009. (Logo:...

2011-02-09 06:00:00

CUPERTINO, Calif., Feb. 9, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today results from a European Phase IIb shoulder clinical trial conducted by Nycomed of POSIDUR(TM) (also known as SABER(TM)-bupivacaine or Optesia(TM) in the E.U.), a proprietary product under development for the treatment of post-surgical pain, and the amendment of the Company's collaboration agreement with Nycomed. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) This shoulder...

2011-01-05 08:00:00

FLORHAM PARK, N.J., Jan. 5, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today that VEREGEN® (sinecatechins) Ointment, 15%, a topical medication for the treatment of external genital and perianal warts (EGWs), has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases (STD) Treatment Guidelines.(1) The new report, developed by the CDC after consultation with a group of...

2010-11-10 12:40:00

MELVILLE, N.Y., Nov. 10, 2010 /PRNewswire/ -- Nycomed US Inc. announced today the appointment of Joseph J. LaRosa as its new Senior Vice President and General Counsel, reporting to Steve Andrzejewski, CEO of Nycomed US. Joe will be the chief legal advisor of the company and oversee all of the company's legal and intellectual property matters. In addition, he will also be responsible for the company's compliance functions. Joe was Vice President, Legal Affairs at Schering-Plough...

2010-11-02 08:00:00

TORONTO and OAKVILLE, Ontario, Nov. 2, 2010 /PRNewswire/ -- The Canadian Pharmaceutical Distribution Network (CPDN) has joined GHX, enabling participating hospitals to gain greater visibility into their pharmaceutical purchasing. CPDN is a service provider to independent drug manufacturers comprising 19 of the leading pharmaceutical companies serving the Canadian hospital market. Approximately 80 percent of Canadian hospitals that maintain accounts with pharmaceutical companies use the...

2010-11-02 07:00:00

CUPERTINO, Calif., Nov. 2, 2010 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it has been awarded grants totaling $733,438 to advance our programs in post-operative pain relief, attention deficit disorder (ADHD) and chronic diseases treated with biologic agents. The grants are being awarded under the Patient Protection and Affordable Care Act of 2010. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) (Logo:...

2010-11-01 06:00:00

ZURICH, Nov. 1, 2010 /PRNewswire/ -- Nycomed has acquired 51.34% of the shares of Guangdong Techpool Bio-Pharma Co., Ltd., a fast-growing Chinese pharmaceutical company based in Guangdong Acquisition demonstrates importance of China as a key part of Nycomed's emerging markets strategy Nycomed gains access to a leading, high quality manufacturer of biologic and protein-based drugs with international potential Creates enhanced commercialization base for Nycomed products including...

2010-08-05 08:00:00

MELVILLE, N.Y., Aug. 5 /PRNewswire/ -- Nycomed US Inc. announced today the appointment of Jeff Wasserstein as its new Sr. Vice President, Business Development and Strategy. Jeff will be responsible for the evaluation and execution of Nycomed US growth strategies to meet US portfolio and financial needs through the execution of in-licensing, acquisitions and out-partnering opportunities. He will report to Steve Andrzejewski, CEO of Nycomed US. Jeff has 20 years experience working in...

2010-08-03 10:53:00

BALTIMORE, Aug. 3 /PRNewswire/ -- Lupin Ltd. today announced the appointment of Paul McGarty as President of its U.S. Subsidiary, Lupin Pharmaceuticals, Inc. Paul has over 25 years experience in the Pharmaceutical Industry spanning across brand and specialty pharmaceutical companies. Most recently, as the CEO of Nycomed U.S., Paul successfully transformed the company from a topical manufacturer into a Dermatology Specialty Company with a brand & generic business. Under his leadership...

2010-07-19 08:00:00

MELVILLE, N.Y., July 19 /PRNewswire/ -- Nycomed US Inc. today announced the appointment of Steve Andrzejewski as the new Chief Executive Officer. He assumes immediate responsibility for Nycomed US Inc., including manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories. Steve Andrzejewski has been working in the pharmaceutical and healthcare industry for more than 20...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.